0001209191-17-046024.txt : 20170721 0001209191-17-046024.hdr.sgml : 20170721 20170721195850 ACCESSION NUMBER: 0001209191-17-046024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170719 FILED AS OF DATE: 20170721 DATE AS OF CHANGE: 20170721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arbuckle Stuart A CENTRAL INDEX KEY: 0001557290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 17977401 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-19 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001557290 Arbuckle Stuart A C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP\Chief Commercial Officer Common Stock 2017-07-19 4 M 0 25500 96.87 A 156967 D Common Stock 2017-07-19 4 M 0 38250 109.14 A 195217 D Common Stock 2017-07-19 4 M 0 14875 131.89 A 210092 D Common Stock 2017-07-19 4 M 0 10775 91.05 A 220867 D Common Stock 2017-07-19 4 S 0 60400 161.00 D 160467 D Common Stock 2017-07-19 4 S 0 29000 162.67 D 131467 D Common Stock 2017-07-21 4 M 0 2125 131.89 A 133592 D Common Stock 2017-07-21 4 S 0 2125 159.00 D 131467 D Common Stock 2017-07-21 4 S 0 10150 161.68 D 121317 D Common Stock 2017-07-21 4 S 0 200 161.72 D 121117 D Common Stock 140 I 401(k) Stock Option (Right to Buy) 96.87 2017-07-19 4 M 0 25500 0.00 D 2024-07-14 Common Stock 25500 8500 D Stock Option (Right to Buy) 109.14 2017-07-19 4 M 0 38250 0.00 D 2025-02-02 Common Stock 38250 38250 D Stock Option (Right to Buy) 131.89 2017-07-19 4 M 0 14875 0.00 D 2025-07-20 Common Stock 14875 19125 D Stock Option (Right to Buy) 91.05 2017-07-19 4 M 0 10775 0.00 D 2026-02-01 Common Stock 10775 23707 D Stock Option (Right to Buy) 131.89 2017-07-21 4 M 0 2125 0.00 D 2025-07-20 Common Stock 2125 17000 D Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 07/15/2014. The option vests in 16 quarterly installments from 02/03/2015. The option vests in 16 quarterly installments from 07/21/2015. The option vests in 16 quarterly installments from 02/02/2016. Omar White, Attorney-In-Fact 2017-07-21